Loading...

ACAD ACADIA PHARMACEUTICALS INC Management Changes 8-K Filing

CD P

CD

ACADIA PHARMACEUTICALS INC

(ACAD)

2025 8-K

Show Summary

Show Summary

Management Changes

Earnings Releases

Bylaw Amendments

Financial Results

Management Change

Q3 Financial Results

Financial Results Announcement

Annual Meeting Approval

Financial Results Announcement

Results of Phase 3 ADVANCE-...

Financial Results Announcement

Departure of Directors

Management Change

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

External Links:

On May 29, 2025, Acadia Pharmaceuticals Inc. held its Annual Meeting, electing three Class III directors and approving executive compensation and Ernst & Young as auditors for 2025.

AI Assistant

ACADIA PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.